Furthermore, infusion of exosomes loaded with ASO-TNF or 2DG attenuated NASH progression by modulating the expression of superoxide dismutase 1 (Sod1) in mice. This evidence concerns the gene SOD1 and metabolic dysfunction-associated steatohepatitis.